Description:
BiomX Inc. (PHGE) is a clinical-stage microbiome company based in Ness Ziona, Israel, specializing in innovative therapies that harness natural and engineered phage technologies to specifically target and eradicate pathogenic bacteria. With a focus on treating chronic diseases associated with dysbiosis, BiomX aims to transform bacterial infection management through its proprietary pipeline of product candidates. The company's approach positions it at the forefront of microbiome research, offering potential solutions in areas such as inflammatory bowel disease, cystic fibrosis, and acne, thereby addressing significant unmet medical needs in the healthcare landscape.
Address:
22 EINSTEIN STREET, NESS ZIONA, ISRAEL, 7414003
Fiscal year end:
December
Market capitalization:
$13.8 Million
Dividend per share:
$0.00
How much was you spent on shares:
$1,000
How much will you earn in
6 years:
-99%
How much will you get:
$5
Prices dates:
13-03-2019: $96.50 and 30-09-2025: $0.53